Changes related to "Bevacizumab (Avastin)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 19:22, 23 June 2018
   
Page name:

23 June 2018

 m   18:17  Esophageal cancer‎‎ (2 changes | history) . . (+3,602). . [Jwarner‎ (2×)]
 m    18:17 (cur | prev) . . (+2,897). . Jwarner (talk | contribs)
 m    09:54 (cur | prev) . . (+705). . Jwarner (talk | contribs) (Metastatic or locally advanced disease (non-radiation/surgery candidate))
 m   17:31  Non-small cell lung cancer‎ (diff | hist) . . (+242). . Jwarner (talk | contribs) (Erlotinib monotherapy {{#subobject:c3c726|Regimen=1}})

22 June 2018

 m   20:30  Melanoma‎‎ (3 changes | history) . . (+4,145). . [Jwarner‎ (3×)]
 m    20:30 (cur | prev) . . (+343). . Jwarner (talk | contribs) (Observation)
 m    20:28 (cur | prev) . . (+3,799). . Jwarner (talk | contribs) (Interferon alfa-2b monotherapy {{#subobject:86bbbb|Regimen=1}})
 m    13:19 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Carboplatin & Paclitaxel, nanoparticle albumin-bound {{#subobject:a013af|Regimen=1}})
     16:33  Non-small cell lung cancer‎‎ (9 changes | history) . . (+18,555). . [Jwarner‎ (9×)]
 m    16:33 (cur | prev) . . (+1,480). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:75f589|Regimen=1}})
 m    15:10 (cur | prev) . . (+1,741). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:75f589|Regimen=1}})
      15:05 (cur | prev) . . (+4,616). . Jwarner (talk | contribs) (Advanced or metastatic disease, first-line)
      14:46 (cur | prev) . . (+2,156). . Jwarner (talk | contribs) (Maintenance after first-line therapy)
      14:38 (cur | prev) . . (+5,171). . Jwarner (talk | contribs) (Carboplatin & Docetaxel {{#subobject:bdce59|Regimen=1}})
 m    13:54 (cur | prev) . . (+3,369). . Jwarner (talk | contribs) (Carboplatin, Paclitaxel, Bevacizumab {{#subobject:1c2c25|Regimen=1}})
 m    13:42 (cur | prev) . . (+67). . Jwarner (talk | contribs)
 m    13:19 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Carboplatin & nab-Paclitaxel {{#subobject:413b7d|Regimen=1}})
 m    13:17 (cur | prev) . . (-49). . Jwarner (talk | contribs)
 m   15:42  Ovarian cancer‎ (diff | hist) . . (-60). . Jwarner (talk | contribs)

21 June 2018

     22:19  Follicular lymphoma‎‎ (2 changes | history) . . (+12,296). . [Jwarner‎ (2×)]
      22:19 (cur | prev) . . (+12,222). . Jwarner (talk | contribs)
 m    20:36 (cur | prev) . . (+74). . Jwarner (talk | contribs)
 m   15:44  Anaplastic glioma‎ (diff | hist) . . (+21). . Jwarner (talk | contribs) (References)

20 June 2018

 m   16:11  Hepatocellular carcinoma‎ (diff | hist) . . (+8). . Jwarner (talk | contribs) (Subsequent treatment)
     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   11:42  Uterine cancer‎ (diff | hist) . . (+30). . Jwarner (talk | contribs)
 m   11:30  Pancreatic NET‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Lanreotide & Interferon alfa {{#subobject:9c5a59|Regimen=1}})
 m   10:46  Esophageal cancer‎ (diff | hist) . . (+180). . Jwarner (talk | contribs) (FOLFOX-C {{#subobject:e51095|Regimen=1}})
 m   10:43  Colon cancer‎ (diff | hist) . . (+288). . Jwarner (talk | contribs)
 m   10:38  Follicular lymphoma‎ (diff | hist) . . (-3,669). . Jwarner (talk | contribs)

19 June 2018

 m   23:01  Esophageal cancer‎ (diff | hist) . . (-35). . Jwarner (talk | contribs)
 m   22:57  Rectal cancer‎‎ (2 changes | history) . . (+151). . [Jwarner‎ (2×)]
 m    22:57 (cur | prev) . . (+79). . Jwarner (talk | contribs) (Fluorouracil, Folinic acid, Levamisole, RT {{#subobject:45b35a|Regimen=1}})
 m    17:51 (cur | prev) . . (+72). . Jwarner (talk | contribs) (Neoadjuvant chemoradiotherapy)
 m   22:46  Follicular lymphoma‎‎ (2 changes | history) . . (+42). . [Jwarner‎ (2×)]
 m    22:46 (cur | prev) . . (-16). . Jwarner (talk | contribs)
 m    22:45 (cur | prev) . . (+58). . Jwarner (talk | contribs) (Advanced disease, first-line therapy, non-randomized or retrospective data)
 m   17:30  Vascular sarcoma‎ (diff | hist) . . (+20). . Jwarner (talk | contribs) (Kaposi sarcoma, all lines of therapy)
 m   17:29  Ovarian cancer‎ (diff | hist) . . (+66). . Jwarner (talk | contribs) (Relapsed or recurrent disease, platinum-resistant)
 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   10:58  Hepatocellular carcinoma‎‎ (7 changes | history) . . (+3,100). . [Jwarner‎ (7×)]
 m    10:58 (cur | prev) . . (+10). . Jwarner (talk | contribs) (Preceding treatment)
 m    10:57 (cur | prev) . . (+24). . Jwarner (talk | contribs) (TACE, then 5-FU {{#subobject:572d2d|Regimen=1}})
 m    10:55 (cur | prev) . . (+1,951). . Jwarner (talk | contribs)
 m    10:34 (cur | prev) . . (0). . Jwarner (talk | contribs) (TACE {{#subobject:50f9da|Regimen=1}})
 m    09:48 (cur | prev) . . (+71). . Jwarner (talk | contribs) (TACE {{#subobject:50f9da|Regimen=1}})
 m    09:22 (cur | prev) . . (+1,003). . Jwarner (talk | contribs) (Sorafenib monotherapy {{#subobject:b38f69|Regimen=1}})
 m    09:19 (cur | prev) . . (+41). . Jwarner (talk | contribs) (Radioembolization {{#subobject:4f040c|Regimen=1}})

18 June 2018

 m   23:14  Esophageal cancer‎ (diff | hist) . . (+149). . Jwarner (talk | contribs)
 m   23:05  Mesothelioma‎ (diff | hist) . . (+82). . Jwarner (talk | contribs) (Advanced or metastatic disease, first-line therapy)
     22:33  Small cell lung cancer‎‎ (2 changes | history) . . (+5,237). . [Jwarner‎ (2×)]
      22:33 (cur | prev) . . (+5,674). . Jwarner (talk | contribs) (Limited stage, consolidation)
 m    22:32 (cur | prev) . . (-437). . Jwarner (talk | contribs) (Limited stage, definitive chemoradiotherapy)